The aim of this trial was to investigate whether a GLP-1 RA as compared with placebo reduces fluid intake in patients with primary polydipsia
The BPC-157 peptide may work by stimulating growth factors to promote healing, but there is no evidence that it will cause muscle growth to improve body composition
Looking ahead, I expect continued development of products and menu items that are smaller in portion size, aligning with reduced appetites, and fortified with protein and other nutrients that must be maintained as overall consumption declines
For some patients, switching from a once-weekly to a once-daily formulation (or vice versa) might alter the side effect profile
The nausea follows a predictable weekly pattern
concerning) How dosing increases gradually over weeks What to do if you experience side effects You'll learn Week 1-2: Possible nausea, loss of appetite (normal) Week 3-4: Body adjusts, side effects usually improve Week 5-8: Appetite suppression peaks, weight loss increases Month 2+: Steady, consistent weight loss Step 4: Medication Safety Screening (5 minutes) The physician will ask Are you pregnant or trying to become pregnant?" (GLP-1 isn't recommended) Any history of thyroid cancer or medullary thyroid cancer?" (Important safety issue) Gallbladder disease, pancreatitis, or kidney problems?" (Need to monitor) Taking any other weight loss medications?" (Can't mix) Allergic to any medications?" (Especially previous allergies to injectables) Why: GLP-1 is safe, but its not appropriate for everyone
